source
- Personalized mRNA melanoma vaccine shows clinical success, reviving optimism for the platformModerna and Merck reported positive results from a personalized mRNA vaccine designed to treat melanoma in a recent clinical study. The outcome is being hailed as a boost for mRNA technology, whic…
- Radiopharmaceutical experts urge pharma to adopt bolder dosing despite safety concernsLouise Emmett and a group of radiopharmaceutical specialists argue that these modern radiation‑based drugs could dramatically improve cancer outcomes if used more aggressively. They say the therapi…